AXSM
Axsome Therapeutics Inc
Price:  
97.74 
USD
Volume:  
481,190.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Axsome WACC - Weighted Average Cost of Capital

The WACC of Axsome Therapeutics Inc (AXSM) is 7.8%.

The Cost of Equity of Axsome Therapeutics Inc (AXSM) is 7.80%.
The Cost of Debt of Axsome Therapeutics Inc (AXSM) is 10.20%.

Range Selected
Cost of equity 6.60% - 9.00% 7.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 13.40% 10.20%
WACC 6.5% - 9.0% 7.8%
WACC

Axsome WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 0.74
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.04 0.04
Cost of debt 7.00% 13.40%
After-tax WACC 6.5% 9.0%
Selected WACC 7.8%